#ClinicalPearl Overall #azathioprine wins for maintenance of remission in ANCA associated #vasculitis with equal remission in MPO+ but less with AZA inPR3+. So use AZA but if not tolerated sometimes MMF is ok. Otherwise consider #Leflunomide or if bad organ involvement #Rituximab https://t.co/efi8cKQ36B
Links:
Richard Conway on Twitter: "Subgroup analysis of IMPROVE study looking at …
https://twitter.com/richardpaconway/status/1511279161092018178
Apr-06-2022
